Acute ischemic heart disease is associated with an elevation of BNP levels, which might reflect the severity of LV dysfunction, and studies have suggested using natriuretic peptide levels as a guide to institute more aggressive treatments for ischemic heart diseases aimed at reducing ventricular wall stress [29]. The gene discussed is NPPB; the disease is coronary artery disorder.